Skip to main content
芭薇股份 logo

芭薇股份 — Investor Relations & Filings

Ticker · 920123 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 240 across all filing types
Latest filing 2024-08-05 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920123

About 芭薇股份

https://www.gzbawei.com/

Guangdong Bawei Biotechnology Corp., Ltd. is a comprehensive beauty and personal care solution provider specializing in research, development, production, and testing. The company offers integrated OEM, ODM, and OBM services, covering a wide range of product categories including skincare, hair care, body care, and makeup. Bawei is recognized for its commitment to scientific innovation, operating advanced R&D laboratories and an independent third-party testing center that ensures product safety and efficacy. By leveraging automated production lines and a rigorous quality management system, the company serves a diverse portfolio of domestic and international brands. Its core focus remains on delivering high-quality, customized formulations and manufacturing excellence to meet evolving consumer demands in the global beauty market.

Recent filings

Filing Released Lang Actions
万联证券股份有限公司关于广东芭薇生物科技股份有限公司追认关联交易事项的核查意见
Regulatory Filings
2024-08-05 Chinese
关于签署募集资金专户存储三方监管协议之补充协议的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the signing of a supplementary agreement related to the supervision of a special account for raised funds. It details the issuance of shares, the amount of funds raised, and the management and use of these funds. The document references regulatory approval from the China Securities Regulatory Commission and mentions specific agreements with banks and securities firms for fund management. It does not contain financial statements or detailed financial performance data but focuses on the update about fundraising and capital management activities. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is short and it is not a report publication announcement or certification. Hence, the classification is CAP with high confidence.
2024-07-10 Chinese
第三届董事会第三十次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolutions from the 30th meeting of the third board of directors of Guangdong Bawei Biotechnology Co., Ltd. It details the meeting's attendance, legality, and the approval of the 2023 Social Responsibility Report. It does not contain the report itself but references that the Social Responsibility Report is disclosed separately on the Beijing Stock Exchange information disclosure platform. The document is short (827 characters) and serves as a formal announcement of board meeting decisions, not the full report. Therefore, it fits best under Board/Management Information (MANG) as it relates to board meeting resolutions and decisions.
2024-06-18 Chinese
2023年社会责任报告
Regulatory Filings
2024-06-18 Chinese
股票解除限售公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the lifting of stock trading restrictions (解除限售公告) for certain shareholders, detailing the number of shares becoming tradable, the reasons for lifting restrictions, and the post-lifting shareholding structure. It includes no financial statements or performance data, nor does it present a report or analysis. The document is regulatory in nature, informing the market about changes in share restrictions and shareholder status. It fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement that does not fit into more specific categories like share issue or capital change (SHA) or major shareholding notification (MRQ). The document length is short (2015 characters), and it is not a report publication announcement or certification. Therefore, the best classification is Regulatory Filings (RNS).
2024-06-11 Chinese
第三届董事会第二十九次会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement of the resolutions passed at the 29th meeting of the third board of directors of Guangdong Bawei Biotechnology Co., Ltd. It details the meeting's time, place, attendance, agenda items, voting results, and related procedural compliance. The content focuses on board decisions, specifically regarding loan applications and related guarantees, and includes references to related disclosures. There is no financial report, audit, or earnings data presented. The document is clearly a board meeting resolution announcement, which fits the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication but a substantive announcement of board decisions.
2024-06-10 Chinese

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.